LONGO, MIRIAM
 Distribuzione geografica
Continente #
EU - Europa 2.501
AS - Asia 946
NA - Nord America 684
SA - Sud America 173
AF - Africa 18
OC - Oceania 1
Totale 4.323
Nazione #
RU - Federazione Russa 1.974
US - Stati Uniti d'America 663
SG - Singapore 322
CN - Cina 222
IE - Irlanda 198
HK - Hong Kong 167
IT - Italia 148
BR - Brasile 139
DE - Germania 77
KR - Corea 70
VN - Vietnam 65
IN - India 39
GB - Regno Unito 20
AR - Argentina 19
JP - Giappone 16
FI - Finlandia 11
FR - Francia 11
NL - Olanda 9
BD - Bangladesh 8
CA - Canada 8
CZ - Repubblica Ceca 8
PL - Polonia 8
TR - Turchia 8
MX - Messico 7
ZA - Sudafrica 7
AT - Austria 5
EC - Ecuador 5
IQ - Iraq 5
LT - Lituania 5
SE - Svezia 5
BE - Belgio 4
PT - Portogallo 4
CH - Svizzera 3
CO - Colombia 3
GR - Grecia 3
ID - Indonesia 3
IR - Iran 3
KE - Kenya 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
CL - Cile 2
DZ - Algeria 2
ES - Italia 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
MA - Marocco 2
PY - Paraguay 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
AU - Australia 1
BH - Bahrain 1
CY - Cipro 1
EG - Egitto 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
VE - Venezuela 1
Totale 4.323
Città #
Moscow 733
Dublin 197
Singapore 168
Hong Kong 165
Santa Clara 133
Chandler 117
Seoul 70
Hefei 56
Ashburn 54
Beijing 51
Naples 42
Munich 35
New York 31
Bengaluru 26
Ho Chi Minh City 24
Bremen 21
Princeton 19
Roxbury 19
Cambridge 17
Los Angeles 16
São Paulo 16
The Dalles 13
Hanoi 12
Salerno 9
Ercolano 8
Boardman 7
Brno 7
Marigliano 7
Brooklyn 6
Lappeenranta 6
Milan 6
Cagliari 5
Helsinki 5
Istanbul 5
London 5
Warsaw 5
Amsterdam 4
Belo Horizonte 4
Brussels 4
Castel Campagnano 4
Da Nang 4
Dallas 4
Formia 4
Guayaquil 4
Nuremberg 4
Rio de Janeiro 4
San Francisco 4
San Gennaro Vesuviano 4
Stockholm 4
Turin 4
Aversa 3
Biên Hòa 3
Boston 3
Boydton 3
Calgary 3
Calitri 3
Campinas 3
Chennai 3
Chennevières-sur-marne 3
Evora 3
Goiânia 3
Johannesburg 3
Lugano 3
Mexico City 3
Nairobi 3
Napoli 3
North Charleston 3
Porto Alegre 3
Pune 3
San Pietro Di Feletto 3
Tianjin 3
Vilnius 3
Ankara 2
Anápolis 2
Araraquara 2
Baku 2
Bishkek 2
Buenos Aires 2
Castel Volturno 2
Chicago 2
Curitiba 2
Cà Mau 2
Denver 2
Des Moines 2
Forlì 2
Formosa 2
Fossano 2
Frankfurt am Main 2
Guangzhou 2
Guararema 2
Hanover 2
Kaunas 2
Krasnodar 2
Marília 2
Mauá 2
Medford 2
Montreal 2
Nola 2
Rondonópolis 2
San Nicola la Strada 2
Totale 2.294
Nome #
Change in circulating levels of endothelial progenitor cells and sexual function in women with type 1 diabetes 162
Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis 143
Applications for social security benefits related to diabetes in the working age in Italy between 2009 and 2019: a nationwide retrospective cohort study 140
Impact of pituitary autoimmunity and genetic disorders on growth hormone deficiency in children and adults 140
Feasibility of simplification from a basal-bolus insulin regimen to a fixed-ratio formulation of basal insulin plus a glp-1ra or to basal insulin plus an SGLT2 inhibitor: BEYOND, a randomized, pragmatic trial 139
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 135
Exploring the performance of ultrasound risk stratification systems in thyroid nodules of pediatric patients 135
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs 132
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues 132
Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADS 130
Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes 128
When amputation is not the end of the challenge: A successful therapy for osteomyelitis and soft tissue infection in a patient with type 1 diabetes 126
Hypothalamic-Pituitary Autoimmunity and Related Impairment of Hormone Secretions in Chronic Fatigue Syndrome 124
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression 122
Neuroimmunoendocrinology of SARS-CoV 2 Infection 118
Varicocele: An Endocrinological Perspective 118
Assessment of Neuroendocrine Changes and Hypothalamo-Pituitary Autoimmunity in Patients with COVID-19 116
Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes 114
Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease: The STARDUST Randomized Clinical Trial 110
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off 110
Prevalence and Management of Complications of Percutaneous Ethanol Injection for Cystic Thyroid Nodules: A Systematic Review of Literature and Meta-analysis 108
Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial 104
Telemedicine for type 2 diabetes during COVID-19 pandemic: experience from a tertiary diabetes center 103
Simplification of complex insulin therapy: a story of dogma and therapeutic resignation 101
Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy 99
Mediterranean diet in type 2 diabetes: An updated overview of pharmacological activities of cardiometabolic and reproductive outcomes 98
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 97
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs 97
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes 97
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs 95
Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules 91
Sleep quality and glucose control in adults with type 1 diabetes during the seasonal daylight saving time shifts 89
Renal and metabolic effects of SGLT-2i and DPP-4i according to basal estimated glomerular filtration rate: Analysis from GIOIA, an observational prospective study 89
Patient-specific factors, patient preference, and nodule size as implications in the initial surgery of high risk indeterminate thyroid nodules 88
Unilateral Graves' disease: a case report with concomitant thyroid cancer and systematic review of literature 86
Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis 83
Reply to the letter to the editor by Mungmunpuntipantip et al 79
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice 75
Fixed-ratio combination of GLP-1 receptor agonist and basal insulin: simplifying type 2 diabetes treatment 75
Signs of a Glucose and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes 67
Totale 4.395
Categoria #
all - tutte 13.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 1 1 0 3 3 0
2021/2022111 0 0 3 0 9 0 4 3 11 18 5 58
2022/2023452 51 9 9 27 75 27 0 27 203 7 6 11
2023/2024242 25 8 10 23 54 47 14 2 4 9 12 34
2024/2025696 12 14 19 13 114 112 101 51 81 78 61 40
2025/20262.870 176 217 168 164 302 1.843 0 0 0 0 0 0
Totale 4.395